User login
A short course of oral prednisone in the outpatient setting prevents relapse and decreases dyspnea in patients with an exacerbation of chronic obstructive pulmonary disease (COPD). However, physicians should be aware of the potential for weight gain, increased appetite, and insomnia in patients taking this medication.
A short course of oral prednisone in the outpatient setting prevents relapse and decreases dyspnea in patients with an exacerbation of chronic obstructive pulmonary disease (COPD). However, physicians should be aware of the potential for weight gain, increased appetite, and insomnia in patients taking this medication.
A short course of oral prednisone in the outpatient setting prevents relapse and decreases dyspnea in patients with an exacerbation of chronic obstructive pulmonary disease (COPD). However, physicians should be aware of the potential for weight gain, increased appetite, and insomnia in patients taking this medication.